Arogyam Medisoft Solution Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 0.78 M
as on 09-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -10.58%
(FY 2022)
- Profit -23.01%
(FY 2022)
- Ebitda -61.17%
(FY 2022)
- Net Worth 0.01%
(FY 2022)
- Total Assets 0.77%
(FY 2022)
About Arogyam Medisoft Solution
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.78 M, as per Ministry of Corporate Affairs (MCA) records.
Rajiv Mondal, Partha Chakraborty, Shamik Basuray, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999WB2016PTC216188
- Company No.
216188
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jun 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Arogyam Medisoft Solution Private Limited offer?
Arogyam Medisoft Solution Private Limited offers a wide range of products and services, including Agricultural & Farm Consultants, Agricultural Testing Service.
Who are the key members and board of directors at Arogyam Medisoft Solution?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Mondal  | Director | 15-Jun-2016 | Current |
| Partha Chakraborty | Director | 01-Sep-2017 | Current |
| Shamik Basuray | Director | 01-Sep-2022 | Current |
| Sumalya Sen | Director | 29-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Arogyam Medisoft Solution.
Arogyam Medisoft Solution Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.58% decrease. The company also saw a substantial fall in profitability, with a 23.01% decrease in profit. The company's net worth moved up by a moderate rise of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arogyam Medisoft Solution?
In 2022, Arogyam Medisoft Solution had a public holding of 9.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arogyam Medisoft Solution?
Unlock and access historical data on people associated with Arogyam Medisoft Solution, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arogyam Medisoft Solution, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arogyam Medisoft Solution's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
